BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 10537136)

  • 1. Dissociation of Janus kinase 2 and signal transducer and activator of transcription 5 activation after treatment of Nb2 cells with a molecular mimic of phosphorylated prolactin.
    Coss D; Kuo CB; Yang L; Ingleton P; Luben R; Walker AM
    Endocrinology; 1999 Nov; 140(11):5087-94. PubMed ID: 10537136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different biological effects of unmodified prolactin and a molecular mimic of phosphorylated prolactin involve different signaling pathways.
    Wu W; Coss D; Lorenson MY; Kuo CB; Xu X; Walker AM
    Biochemistry; 2003 Jun; 42(24):7561-70. PubMed ID: 12809512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of functional prolactin receptors in nonpregnant human endometrium: janus kinase-2, signal transducer and activator of transcription-1 (STAT1), and STAT5 proteins are phosphorylated after stimulation with prolactin.
    Jabbour HN; Critchley HO; Boddy SC
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2545-53. PubMed ID: 9661641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C.
    Fernández L; Flores-Morales A; Lahuna O; Sliva D; Norstedt G; Haldosén LA; Mode A; Gustafsson JA
    Endocrinology; 1998 Apr; 139(4):1815-24. PubMed ID: 9528967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinctive roles for prolactin and growth hormone in the activation of signal transducer and activator of transcription 5 in pancreatic islets of langerhans.
    Brelje TC; Stout LE; Bhagroo NV; Sorenson RL
    Endocrinology; 2004 Sep; 145(9):4162-75. PubMed ID: 15142985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
    Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
    Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of signal transducer and activator of transcription (STAT) 5b activation by the temporal pattern of growth hormone stimulation.
    Gebert CA; Park SH; Waxman DJ
    Mol Endocrinol; 1997 Apr; 11(4):400-14. PubMed ID: 9092792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Convergence of signaling transduced by prolactin (PRL)/cytokine chimeric receptors on PRL-responsive gene transcription.
    Ferrag F; Chiarenza A; Goffin V; Kelly PA
    Mol Endocrinol; 1996 Apr; 10(4):451-60. PubMed ID: 8721989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRL-induced ERalpha gene expression is mediated by Janus kinase 2 (Jak2) while signal transducer and activator of transcription 5b (Stat5b) phosphorylation involves Jak2 and a second tyrosine kinase.
    Frasor J; Barkai U; Zhong L; Fazleabas AT; Gibori G
    Mol Endocrinol; 2001 Nov; 15(11):1941-52. PubMed ID: 11682625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S179D-human PRL, a pseudophosphorylated human PRL analog, is an agonist and not an antagonist.
    Bernichtein S; Kinet S; Jeay S; Llovera M; Madern D; Martial JA; Kelly PA; Goffin V
    Endocrinology; 2001 Sep; 142(9):3950-63. PubMed ID: 11517174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JAK2 and STAT5, but not JAK1 and STAT1, are required for prolactin-induced beta-lactoglobulin transcription.
    Han Y; Watling D; Rogers NC; Stark GR
    Mol Endocrinol; 1997 Jul; 11(8):1180-8. PubMed ID: 9212064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the Jak2-Stat5 signaling pathway in Nb2 lymphoma cells by an anti-apoptotic agent, aurintricarboxylic acid.
    Rui H; Xu J; Mehta S; Fang H; Williams J; Dong F; Grimley PM
    J Biol Chem; 1998 Jan; 273(1):28-32. PubMed ID: 9417042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactogenic hormone-inducible phosphorylation and gamma-activated site-binding activities of Stat5b in primary rat Leydig cells and MA-10 mouse Leydig tumor cells.
    Kanzaki M; Morris PL
    Endocrinology; 1998 Apr; 139(4):1872-82. PubMed ID: 9528973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Janus kinase 2 (JAK2) regulates prolactin-mediated chloride transport in mouse mammary epithelial cells through tyrosine phosphorylation of Na+-K+-2Cl- cotransporter.
    Selvaraj NG; Omi E; Gibori G; Rao MC
    Mol Endocrinol; 2000 Dec; 14(12):2054-65. PubMed ID: 11117534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin signal transduction to milk protein genes: carboxy-terminal part of the prolactin receptor and its tyrosine phosphorylation are not obligatory for JAK2 and STAT5 activation.
    Goupille O; Daniel N; Bignon C; Jolivet G; Djiane J
    Mol Cell Endocrinol; 1997 Mar; 127(2):155-69. PubMed ID: 9099911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine docking sites of the rat prolactin receptor required for association and activation of stat5.
    Pezet A; Ferrag F; Kelly PA; Edery M
    J Biol Chem; 1997 Oct; 272(40):25043-50. PubMed ID: 9312112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro interaction between STAT 5 and JAK 2; dependence upon phosphorylation status of STAT 5 and JAK 2.
    Flores-Morales A; Pircher TJ; Silvennoinen O; Gustafsson JA; Sanchez-Gomez M; Norstedt G; Haldosén LA; Wood TJ
    Mol Cell Endocrinol; 1998 Mar; 138(1-2):1-10. PubMed ID: 9685210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual mechanism of signal transducer and activator of transcription 5 activation by the insulin receptor.
    Le MN; Kohanski RA; Wang LH; Sadowski HB
    Mol Endocrinol; 2002 Dec; 16(12):2764-79. PubMed ID: 12456798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of recombinant human prolactin receptor antagonists by molecular mimicry of the phosphorylated hormone.
    Chen TJ; Kuo CB; Tsai KF; Liu JW; Chen DY; Walker AM
    Endocrinology; 1998 Feb; 139(2):609-16. PubMed ID: 9449632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of prolactin (PRL)-induced proliferative signals in breast cancer cells by a molecular mimic of phosphorylated PRL, S179D-PRL.
    Schroeder MD; Brockman JL; Walker AM; Schuler LA
    Endocrinology; 2003 Dec; 144(12):5300-7. PubMed ID: 12970160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.